Verastem (VSTM) Non-Current Deffered Revenue (2011 - 2013)
Verastem (VSTM) recorded quarterly Non-Current Deffered Revenue of $16000.0 in Q2 2013, down 42.86% quarter-over-quarter from $28000.0 in Q1 2013, and down 71.93% on a YoY basis from $57000.0 in Q2 2012.
Verastem (VSTM) Non-Current Deffered Revenue (2011 - 2013) Analysis & Trends
Verastem's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $16000.0 for Q2 2013.
- In Q2 2013, Non-Current Deffered Revenue fell 71.93% year-over-year to $16000.0; the TTM figure through Jun 2013 stood at $16000.0 (down 71.93% YoY), while the FY2012 annual figure was $38000.0, down 48.65% from the prior year.
- Non-Current Deffered Revenue was $16000.0 for Q2 2013 at Verastem, down from $28000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $74000.0 in Q4 2011 to a low of $16000.0 in Q2 2013.
- Historically, Non-Current Deffered Revenue has averaged $46571.4 across 3 years, with a median of $47000.0 in 2012.
- The sharpest annual moves came in 2012 and 2013: Non-Current Deffered Revenue plunged 48.65% in 2012, then plunged 71.93% in 2013.
- A 3-year view of Non-Current Deffered Revenue shows it stood at $74000.0 in 2011, then slumped by 48.65% to $38000.0 in 2012, then sank by 57.89% to $16000.0 in 2013.
- The last three Non-Current Deffered Revenue figures came in at $16000.0 (Q2 2013), $28000.0 (Q1 2013), and $38000.0 (Q4 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 16,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 38,000.00 |
| Sep 30, 2012 | 47,000.00 |
| Jun 30, 2012 | 57,000.00 |
| Mar 31, 2012 | 66,000.00 |
| Dec 31, 2011 | 74,000.00 |